Search details
1.
A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.
J Immunol
; 196(4): 1732-40, 2016 Feb 15.
Article
in English
| MEDLINE | ID: mdl-26773149
2.
Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein.
Nature
; 457(7229): 585-8, 2009 Jan 29.
Article
in English
| MEDLINE | ID: mdl-19060881
3.
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity.
Oncoimmunology
; 13(1): 2316945, 2024.
Article
in English
| MEDLINE | ID: mdl-38379869
4.
A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand binding.
J Immunol
; 186(7): 4213-22, 2011 Apr 01.
Article
in English
| MEDLINE | ID: mdl-21383246
5.
Molecular characterization of the interaction between sialylated Neisseria gonorrhoeae and factor H.
J Biol Chem
; 286(25): 22235-42, 2011 Jun 24.
Article
in English
| MEDLINE | ID: mdl-21531728
6.
IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients.
J Immunol
; 182(1): 588-95, 2009 Jan 01.
Article
in English
| MEDLINE | ID: mdl-19109192
7.
LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
J Exp Med
; 198(7): 1043-55, 2003 Oct 06.
Article
in English
| MEDLINE | ID: mdl-14517278
8.
Phagocytosis and intracellular killing of MD-2 opsonized gram-negative bacteria depend on TLR4 signaling.
Blood
; 111(9): 4637-45, 2008 May 01.
Article
in English
| MEDLINE | ID: mdl-18203953
9.
MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4).
J Leukoc Biol
; 80(6): 1584-92, 2006 Dec.
Article
in English
| MEDLINE | ID: mdl-16946018
11.
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?
Oncogene
; 22(42): 6564-9, 2003 Sep 29.
Article
in English
| MEDLINE | ID: mdl-14528281
12.
Inhibition of TLR-4/MD-2 signaling by RP105/MD-1.
J Endotoxin Res
; 11(6): 363-8, 2005.
Article
in English
| MEDLINE | ID: mdl-16303092
13.
Novel Anti-TM4SF1 Antibody-Drug Conjugates with Activity against Tumor Cells and Tumor Vasculature.
Mol Cancer Ther
; 14(8): 1868-76, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26089370
14.
Mechanisms of TLR9 activation.
J Endotoxin Res
; 10(6): 406-12, 2004.
Article
in English
| MEDLINE | ID: mdl-15588423
15.
The LPS receptor generates inflammatory signals from the cell surface.
J Endotoxin Res
; 9(6): 375-80, 2003.
Article
in English
| MEDLINE | ID: mdl-14733724
16.
The functional repertoire of rabbit antibodies and antibody discovery via next-generation sequencing.
MAbs
; 6(3): 628-36, 2014.
Article
in English
| MEDLINE | ID: mdl-24481222
17.
Bacterial fimbriae stimulate proinflammatory activation in the endothelium through distinct TLRs.
J Immunol
; 180(4): 2187-95, 2008 Feb 15.
Article
in English
| MEDLINE | ID: mdl-18250425
18.
Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion.
J Immunol
; 180(5): 3426-35, 2008 Mar 01.
Article
in English
| MEDLINE | ID: mdl-18292569
19.
Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9.
Proc Natl Acad Sci U S A
; 104(6): 1919-24, 2007 Feb 06.
Article
in English
| MEDLINE | ID: mdl-17261807
20.
Ligand-induced conformational changes allosterically activate Toll-like receptor 9.
Nat Immunol
; 8(7): 772-9, 2007 Jul.
Article
in English
| MEDLINE | ID: mdl-17572678